M.V.I. PEDIATRIC
Clinical safety rating: caution
Comprehensive clinical and safety monograph for M.V.I. PEDIATRIC (M.V.I. PEDIATRIC).
Multivitamin preparation providing essential vitamins (A, C, D, E, K, B1, B2, B3, B5, B6, B7, B9, B12) as cofactors for enzymatic reactions, antioxidant functions, and maintenance of normal metabolic processes.
| Metabolism | Vitamins are metabolized via various pathways: water-soluble vitamins (B complex, C) are primarily metabolized in the liver and excreted renally; fat-soluble vitamins (A, D, E, K) are stored in adipose tissue and liver, metabolized via hepatic enzymes, and excreted in bile/feces. |
| Excretion | Renal: 60-80% (free vitamins), Biliary/fecal: 10-20% (unabsorbed and metabolites). |
| Half-life | Variable; vitamin A: 9-25 days (stored in liver), vitamin D: 2-3 weeks (fat-soluble), vitamin C: 10-20 hours (renal function dependent), B-complex: 1-10 hours. Clinical context: accumulation risk in renal impairment. |
| Protein binding | Vitamin A: 90% (retinol-binding protein); Vitamin D: 85-90% (vitamin D-binding protein); Vitamin E: 90% (lipoproteins); Vitamin K: 99% (lipoproteins); B12: 90% (transcobalamins); other B vitamins: minimal to moderate (10-30%). |
| Volume of Distribution | 0.5-1.0 L/kg for water-soluble; 1.5-3.0 L/kg for fat-soluble (due to tissue storage). Clinical meaning: extensive tissue distribution, especially liver for fat-soluble vitamins. |
| Bioavailability | IV: 100% (only route); other routes not recommended (IM or SC may cause tissue damage or unpredictable absorption with fat-soluble vitamins). |
| Onset of Action | Intravenous: 30-60 minutes for water-soluble vitamins; fat-soluble vitamins (A, D, E, K) uptake over 2-4 hours due to tissue distribution. |
| Duration of Action | Water-soluble vitamins: 8-12 hours (excess excreted); fat-soluble vitamins: weeks to months (liver storage). Clinical note: therapeutic effects persist longer with fat-soluble vitamins due to slow release from storage sites. |
Intravenous infusion: 5 mL (1 vial) added to appropriate IV fluid, administered over 30 minutes daily.
| Dosage form | FOR SOLUTION |
| Renal impairment | No specific dose adjustment required; however, caution in severe renal impairment due to potential accumulation of vitamins. |
| Liver impairment | No specific dose adjustment required; monitor for vitamin A toxicity in Child-Pugh Class B/C. |
| Pediatric use | Children 11 years and younger: 5 mL (1 vial) intravenously daily. For infants <1 year, use M.V.I. Pediatric only per manufacturer guidelines. |
| Geriatric use | No specific dose adjustment; monitor renal function and vitamin levels with prolonged use. |
| 1st trimester | Consult provider |
| 2nd trimester | Consult provider |
| 3rd trimester | Consult provider |
Clinical note
Comprehensive clinical and safety monograph for M.V.I. PEDIATRIC (M.V.I. PEDIATRIC).
| Breastfeeding | Compatible with breastfeeding. Vitamins and minerals in M.V.I. PEDIATRIC are natural constituents of human milk. M/P ratios not established for the multi-vitamin mixture; individual vitamins transfer minimally. No adverse effects reported in nursed infants. |
| Teratogenic Risk | M.V.I. PEDIATRIC contains vitamins and minerals at recommended daily allowances. Vitamin A (retinol) at doses below 10,000 IU/day is not associated with increased teratogenic risk; however, high doses (>10,000 IU/day) are teratogenic. The product's vitamin A content (2300 IU per 5 mL) is below the teratogenic threshold. No known teratogenic effects from other components at physiological doses. For all trimesters, use is considered safe when administered according to recommended doses. |
■ FDA Black Box Warning
Not applicable.
| Serious Effects |
["Hypersensitivity to any component.","Pre-existing hypervitaminosis (e.g., vitamin A, D).","Severe renal impairment with inability to excrete aluminum."]
| Precautions | ["Contains vitamin K; caution in patients on anticoagulants (may antagonize warfarin).","Contains aluminum; may accumulate with prolonged use in renal impairment.","Risk of allergic reactions including anaphylaxis (especially with vitamin B1/thiamine).","Monitor liver function due to potential hepatotoxicity with high doses of vitamin A.","Do not exceed recommended doses to avoid toxicity (especially fat-soluble vitamins)."] |
Loading safety data…
| Fetal Monitoring | No specific monitoring required beyond routine prenatal care. Monitor for signs of vitamin toxicity if prolonged use or high doses, particularly serum vitamin A and D levels in cases of overdose risk. |
| Fertility Effects | No adverse effects on fertility reported. Adequate micronutrient status supports normal reproductive function. |